Menu
Live News EQUITY M impact

MLTX Prices $200M Offering

MoonLake Immunotherapeutics prices upsized $200M public offering of 9M Class A ordinary shares at $20.00 per share

MLTX

Reported Earlier, MoonLake Immunotherapeutics Prices Upsized $200M Public Offering Of 9M Class A Ordinary Shares At $20.00 Per Share